159 related articles for article (PubMed ID: 26557937)
21. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
[TBL] [Abstract][Full Text] [Related]
22. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
Dimitroulia E; Pitiriga VC; Piperaki ET; Spanakis NE; Tsakris A
Dis Colon Rectum; 2013 Mar; 56(3):322-7. PubMed ID: 23392146
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children.
My LT; Lien le B; Hsieh WC; Imamura T; Anh TN; Anh PN; Hung NT; Tseng FC; Chi CY; Dao NT; Le DT; Thinh le Q; Tung TT; Imashuku S; Thuong TC; Su IJ
Br J Haematol; 2010 Jan; 148(2):301-10. PubMed ID: 19863536
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in the management of haemophagocytic lymphohistiocytosis.
Imashuku S; Teramura T; Morimoto A; Hibi S
Expert Opin Pharmacother; 2001 Sep; 2(9):1437-48. PubMed ID: 11585022
[TBL] [Abstract][Full Text] [Related]
27. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
28. Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
Luber RP; Honap S; Cunningham G; Irving PM
Front Med (Lausanne); 2019; 6():279. PubMed ID: 31850357
[TBL] [Abstract][Full Text] [Related]
29. Severe complication during remission of Crohn's disease: hemophagocytic lymphohistiocytosis due to acute cytomegalovirus infection.
Miechowiecki J; Stainer W; Wallner G; Tuppy H; Aichinger W; Prammer W; Kirchgatterer A
Z Gastroenterol; 2018 Mar; 56(3):259-263. PubMed ID: 29529681
[TBL] [Abstract][Full Text] [Related]
30. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
31. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.
Lehmberg K; Sprekels B; Nichols KE; Woessmann W; Müller I; Suttorp M; Bernig T; Beutel K; Bode SF; Kentouche K; Kolb R; Längler A; Minkov M; Schilling FH; Schmid I; Vieth S; Ehl S; Zur Stadt U; Janka GE
Br J Haematol; 2015 Aug; 170(4):539-49. PubMed ID: 25940575
[TBL] [Abstract][Full Text] [Related]
32. Systematic review: macrophage activation syndrome in inflammatory bowel disease.
Fries W; Cottone M; Cascio A
Aliment Pharmacol Ther; 2013 Jun; 37(11):1033-45. PubMed ID: 23565820
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome.
Pasic S; Micic D; Kuzmanovic M
Acta Paediatr; 2003 Jul; 92(7):859-61. PubMed ID: 12892170
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.
Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Berghmans N; Boon L; Wouters C; Snoeck R; Andrei G; Matthys P
Clin Exp Immunol; 2018 Apr; 192(1):104-119. PubMed ID: 29178470
[TBL] [Abstract][Full Text] [Related]
35. A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
Honkila M; Niinimäki R; Taskinen M; Kuismin O; Kettunen K; Saarela J; Turunen S; Renko M; Tapiainen T
BMC Infect Dis; 2019 May; 19(1):404. PubMed ID: 31077135
[TBL] [Abstract][Full Text] [Related]
36. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
37. Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital.
Karlsson T
Ups J Med Sci; 2015; 120(4):257-62. PubMed ID: 26212358
[TBL] [Abstract][Full Text] [Related]
38. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
[TBL] [Abstract][Full Text] [Related]
39. Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years.
Strenger V; Merth G; Lackner H; Aberle SW; Kessler HH; Seidel MG; Schwinger W; Sperl D; Sovinz P; Karastaneva A; Benesch M; Urban C
Ann Hematol; 2018 Jun; 97(6):989-998. PubMed ID: 29411124
[TBL] [Abstract][Full Text] [Related]
40. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
